Go to Advanced Search
CTGF |
LOCUS ID | 1490 | |||||||||||||||||||
GENE_SYMBOL | CTGF | |||||||||||||||||||
GENE NAME | connective tissue gr | |||||||||||||||||||
SYNONYMNS | CCN2, NOV2, HCS24, IGFBP8 | |||||||||||||||||||
CHROMOSOME | 6 | |||||||||||||||||||
HOMOLOGENE ID | 1431 |
microRNAs | NA | NA |
GENE SUMMARY |
---|
The protein encoded by this gene is a mitogen that is secreted by vascular endothelial cells. The encoded protein plays a role in chondrocyte proliferation and differentiation, cell adhesion in many cell types, and is related to platelet-derived growth factor. Certain polymorphisms in this gene have been linked with a higher incidence of systemic sclerosis. [provided by RefSeq, Nov 2009] |
OBSERVATIONS |
---|
Complication | Evidence | PMID |
Nephropathy | 1. Connective Tissue Growth Factor (CTGF/CCN2) is an important mediator of kidney fibrosis. | 23199377 |
Retinopathy | 1. In mice infused with exogenous Advanced glycation end product (AGE), Cyr61 expression increased fourfold and Ctgf expression increased two fold in the retina. | 17333105 |
Neuropathy | 1. In this study, CTGF, HO-1 and NT-3 were highly correlated with type 2 diabetic peripheral neuropathy. The conduction velocity of nerve increased with the increase of CTGF, HO-1 and NT-3. Immune cytokine TGF-?1 combined with cattle encephalon glycoside and ignotin injection could improve the contents of CTGF, HO-1 and NT-3, and be better to treat the peripheral neuropathy of type 2 diabetes. | 29259937 |
Cardiovascular | 1. CONCLUSIONS: Our study indicates that high levels of CTGF/CCN2 predict future MI and cardiovascular death in patients with type 2 diabetes. \302\251 2018 by the American Diabetes Association. | 29382658 |